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Ubiquitination is a common posttranslational modification in eukaryotic cells, influencing many fundamental
cellular processes. Defects in ubiquitination and the processes it mediates are involved in many human disease
states. The ubiquitination of a substrate involves four classes of enzymes: a ubiquitin-activating enzyme (E1), a
ubiquitin-conjugating enzyme (E2), a ubiquitin protein ligase (E3), and a de-ubiquitinating enzyme (DUB). A
substantial number of E1s (four), E2s (13), E3s (97), and DUBs (six) that were previously unknown in the mouse
are included in the FANTOM2 Representative Transcript and Protein Set (RTPS). Many of the genes encoding
these proteins will constitute promising candidates for involvement in disease. In addition, the RTPS provides the
basis for the most comprehensive survey of ubiquitination-associated proteins across eukaryotes undertaken to
date. Comparisons of these proteins across human and other organisms suggest that eukaryotic evolution has
been associated with an increase in the number and diversity of E3s (possessing either zinc-finger RING, F-box,
or HECT domains) and DUBs (containing the ubiquitin thiolesterase family 2 domain). These increases in
numbers are too large to be accounted for by the presence of fragmentary proteins in the data sets examined.
Much of this innovation appears to have been associated with the emergence of multicellular organisms, and
subsequently of vertebrates, increasing the opportunity for complex regulation of ubiquitination-mediated
cellular and developmental processes.
Ubiquitination is a central process in eukaryotic cells, influ-
encing meiosis, cellular proliferation, and development. It is
now seen as the most common posttranslational modifica-
tion in all eukaryotes after phosphorylation. Until recently, it
was thought that ubiquitin was simply a cellular label to tar-
get proteins for destruction in the proteasome, but it is now
known to have additional roles in trafficking, kinase activa-
tion, and regulating gene expression (Conaway et al. 2002).
These different roles are associated with different multi-
ubiquitin chains, differing according to the particular lysine
residue, within the ubiquitin molecules, which is used to in-
terlink the chain (Weissman 2001). It appears that these dif-
ferent multi-ubiquitin chains, together with mono-
ubiquitination, act as signals in different cell processes. De-
fects in ubiquitination are known to be involved in many
human disease states such as developmental abnormalities,
autoimmunity, neurodegenerative diseases (Alzheimer’s dis-
ease, Parkinson’s disease, Down’s syndrome, and normal ag-
ing of the brain), and cancer (Weissman 2001). Ubiquitina-
tion is a multistep process requiring four classes of enzyme: a
ubiquitin-activating enzyme (E1), a ubiquitin-conjugating en-
zyme (E2), a ubiquitin protein ligase (E3), and a de-
ubiquitinating enzyme (DUB). Each of these four classes con-
tain characteristic domains represented in the InterPro do-
main database (Apweiler et al. 2000).
Ubiquitination begins when the E1 recruits ubiquitin in
an ATP-dependent process; then the E2 accepts ubiquitin
from the E1. The E3 catalyzes the transfer of ubiquitin from
the E2 to the substrate. At the proteasome, DUBs cleave multi-
ubiquitin chains from substrates and disassemble the chains.
This ensures that ubiquitinated proteins remain associated
with the proteasome and prevents the accumulation of re-
sidual multi-ubiquitin chains that can disrupt proteasome ac-
tivity. DUBs also process immature ubiquitin, which is trans-
lated as a fusion protein that is either a chain of ubiquitin
molecules or joined to small ribosomal subunits (Weissman
2001). The flexibility and complexity of cellular regulation by
ubiquitination can be increased at each stage by increasing
the numbers of proteins in each of the four classes. For ex-
ample, many E3s are SCF (Skp1-Cullin-F-box protein) com-
plexes composed of proteins containing four InterPro do-
mains: SKP1 component (IPR001232), F-box (IPR001810),
Cullin (IPR001373), and zinc-finger RING (IPR001841; Jack-
son and Eldridge 2002). The large numbers of proteins con-
taining these domains mean that a huge number of different
E3 complexes, recognizing a wide range of protein substrates,
can be formed.
The Representative Transcript and Protein Set (RTPS)
amalgamates cDNA clones produced in the recent RIKEN
FANTOM2 project with other publicly available cDNA se-
quences to provide the first overview of the mouse transcrip-
tome (The FANTOM Consortium and the RIKEN GER Group
Phase I and II Team 2002). Previous comparisons of ubiquiti-
nation-associated (UA) proteins between species such as hu-
man, Caenorhabditis elegans, and yeast have suggested that the
numbers and compositions of E2 and E3 proteins are related
to developmental complexity (Von Arnim 2001; Jones et al.
2002). The RTPS provides valuable additional data to investi-
gate such assertions and also to seek putatively vertebrate spe-
cific features of ubiquitination. In the present study, we de-
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scribe the numbers and architectures of proteins containing
UA InterPro domains across the known mouse proteome, in
the light of the RTPS. These data are compared with the
equivalent data from human, Drosophila melanogaster, C. el-
egans, Schizosaccharomyces pombe, and Saccharomyces cerevisiae
proteomes. This study represents the most comprehensive
survey of UA proteins across eukaryotes undertaken to date.
RESULTS
Table 1 shows the numbers of UA proteins present in three
incomplete versions of the mouse proteome: the RTPS, a ver-
sion derived from the SWISS-PROT and TrEMBL databases
(SPTR), and a version derived from SWISS-PROT, TrEMBL, and
the mouse Ensembl database (SPTRENS). It shows that the
number of UA proteins within the RTPS exceeds the number
within SPTR and constitutes more than three fourths of the
number within SPTRENS. This suggests that the RTPS provides
substantial coverage of the mouse transcriptome, because the
SPTRENS includes proteins predicted from a high-quality
mouse genome assembly produced by the Mouse Genome
Sequencing Consortium (which has around seven times the
coverage and covers an estimated 96% of the mouse euchro-
matic genome; see http://www.ensembl.org/Mus_musculus/).
Of the 496 proteins present in the RTPS, 146 (30%) were
found to be absent from the SPTRENS set (i.e., they lacked a
matching sequence of 98% identity over 20 residues). Sig-
nificant numbers of novel mouse proteins belonging to each
enzyme class were discovered, though many have close hu-
man homologs.
The novel UA proteins from the RTPS were combined
with those from the SPTRENS set to provide the most com-
plete set of mouse UA proteins possible; this combined set was
then compared with sets of UA proteins from five other
“draft” or completely sequenced organisms. Table 2 shows
that higher numbers of E1 and E2 proteins are found inmouse
and human than in the other organisms examined. This is
also true of E3 proteins if one ignores the very high number of
F-box (IPR001810) proteins in C. elegans (which remains mys-
terious; Kipreos and Pagano 2000), and the same observations
can also be made of the remaining two classes (DUB and non-
applicable [N/A] proteins). The differences and similarities be-
tween these organisms are often clearer at the level of the
domains that define the enzyme classes. Within E3 proteins,
the largest differences between organisms are seen in zinc-
finger RING (IPR001841) or HECT (IPR000569) domains in
particular, whereas within DUBs, the ubiquitin thiolesterase
family 2 (IPR001394) domain shows the largest differences.
Within the N/A class, the largest differences are seen for the
ubiquitin interacting motif (UIM; IPR003903) and the UBA
domain (IPR000626), but also for the UBX domain
(IPR001012) and the CUE domain (IPR003892).
Comparisons between species that rely solely upon the
numbers of proteins within each enzyme class omit valuable
information about the architectures of the proteins con-
cerned. In particular, many of the UA proteins identified pos-
sess additional InterPro domains, not directly related to ubiq-
uitination, with known or inferred functions (“non-UA do-
mains”). Table 3 shows the numbers of additional, non-UA
domains in UA proteins from each class. From Table 3, it is
possible to see the ratio of the numbers of non-UA domains to
the number of proteins they are present within. Usually, this
ratio is ∼1, reflecting little redundancy in domain composi-
Table 1. Mouse Ubiquitination-Associated Proteins From Three Different Data Sets, Categorized by InterPro Domains and
Enzyme Class
Class InterPro acc RTPS SPTR SPTRENS InterPro domain name
E1 IPR000594 12 (4) 8 9 UBA/THIF-type NAD/FAD binding fold
IPR000127 6 (1) 6 7 Ubiquitin-activating enzyme repeat domain
IPR000011 2 (0) 4 4 Ubiquitin-activating enzyme
Total E1 12 (4) 14 16
E2 IPR000608 40 (13) 24 48 Ubiquitin-conjugating enzymes
E3 IPR001810 56 (21) 34 53 F-box
IPR001373 9 (5) 2 4 Cullin
IPR000569 24 (5) 14 33 HECT domain (ubiquitin-protein ligase)
IPR003126 3 (1) 1 7 Zinc-finger in N-recognin (putative)
IPR001841 192 (61) 143 244 Zinc-finger, RING
IPR001232 2 (0) 2 3 SKP1 component
IPR003613 8 (4) 3 4 Zinc-finger, modified RING (U-box)
Total E3 292 (97) 287 431
DUB IPR001578 5 (0) 5 5 Ubiquitin C-terminal hydrolase, family 1
IPR001394 40 (5) 30 65 Ubiquitin thiolesterase, family 2
IPR001607 10 (2) 8 19 Zinc-finger in ubiquitin thiolesterase
Total DUB 48 (6) 44 79
N/A IPR000626 48 (12) 38 70 Ubiquitin domain
IPR000449 38 (9) 32 60 Ubiquitin-associated (UBA) domain
IPR001012 11 (6) 6 11 UBX domain
IPR003892 8 (1) 6 10 CUE domain
IPR003903 15 (3) 12 16 Ubiquitin interacting motif (UIM)
IPR004854 1 (0) 1 1 Ubiquitin fusion degradation protein UFD1
Total N/A 101 (26) 103 173
TOTAL 496 (146) 352 630
The numbers of novel proteins, not present in the other sets, are indicated in parentheses. The N/A class contains proteins possessing domains
that do not yet have well understood roles in the other four classes.





tion between proteins within a class; this trend is clearest
within E1 and E2 proteins. The most noticeable exceptions to
this are human and C. elegans E3 proteins, in which the vari-
ous non-UA domains are distributed among more than 2.5
times the number of E3 proteins. More modest levels of re-
dundancy in domain composition are seen within E3 proteins
from every other organism except S. cerevisiae, within DUB
proteins from most organisms and within human and mouse
N/A proteins. The full domain architecture for any protein
encoded by a FANTOM2 clone can be examined in the online
FANTOMDB annotation database (http://fantom2.gsc.riken.
go.jp/db/), which can be searched with InterPro domain ac-
cession numbers.
Eight non-UA domains were found to be present within
UA proteins from every species examined: NAD binding site
(IPR000205), RNA-binding region RNP-1 (IPR000504; found
in a variety of RNA binding proteins), sevenfold repeat in
clathrin and VPS proteins (IPR000547; may be involved with
endocytosis), zinc-finger, C-x8-C-x5-C-x3-H type (IPR000571;
involved in cell cycle– or growth phase–related regulation and
splicing), zinc-finger C2H2 type (IPR000822; responsible for
RNA and DNA binding), TPR repeat (IPR001440; a protein–
protein interaction motif), G protein- WD-40 repeat
(IPR001680; present in signal transduction proteins), and
zinc-finger cysteine-rich C6HC (IPR002867; function un-
known). All of these domains are found in combination with
E3 proteins containing either zinc-finger RING (IPR001841)
or F-box (IPR001810) domains within every species. In addi-
tion, within the human proteome, two of these non-UA do-
mains (IPR000822, IPR001440) have been recruited to ubiq-
uitin thiolesterase family 2 (IPR001394) containing DUBs. A
further four non-UA domains were found within UA proteins
from every multicellular organism studied but at the same
time were absent fromUA proteins from the two yeast species:
zinc-finger ZZ type (IPR000433), basic helix-loop-helix dimer-
ization domain (IPR001092), tyrosine protein kinase













E1 4 (9) 7 (16) 8 (9) 5 (7) 4 (6) 2 (4)
E2 5 (4) 1 (1) 7 (7) 3 (4) 0 (0) 0 (0)
E3 114 (325) 49 (62) 87 (101) 123 (321) 46 (49) 32 (30)
DUB 17 (21) 4 (9) 11 (8) 14 (18) 10 (9) 6 (8)
N/A 61 (99) 18 (29) 49 (39) 41 (31) 36 (24) 20 (16)
Total 147 (430) 57 (64) 128 (151) 156 (365) 79 (80) 47 (50)
Numbers of proteins in parentheses.
Table 2. The Numbers of Ubiquitination-Associated Proteins Encoded in Six Draft/Finished Eukaryotic Genomes, Categorized by














E1 IPR000594 14 13 11 9 9 8
IPR000127 7 8 3 4 3 3
IPR000011 2 4 1 1 2 2
Total E1 16 16 11 9 9 8
E2 IPR000608 53 61 32 25 14 15
E3 IPR001810 78 74 34 434 13 14
IPR001373 10 9 7 10 4 5
IPR000569 38 38 13 10 7 5
IPR003126 7 8 6 6 3 2
IPR001841 385 305 121 170 51 40
IPR001232 6 3 8 26 2 2
IPR003613 9 8 6 4 3 2
Total E3 527 442 189 657 82 68
DUB IPR001578 4 5 5 3 2 1
IPR001394 67 70 21 33 16 18
IPR001607 14 21 5 6 6 4
Total DUB 74 78 27 39 20 20
N/A IPR000626 69 82 27 30 17 9
IPR000449 65 69 28 19 12 9
IPR001012 19 17 8 5 5 7
IPR003892 11 11 4 4 3 7
IPR003903 30 19 8 7 6 7
IPR004854 1 1 1 2 1 1
Total N/A 184 187 63 57 39 35
TOTAL 835 764 320 785 162 145




(IPR001245), and ankyrin repeat (IPR002110). Apart from the
tyrosine protein kinase domain (IPR001245), these non-UA
domains are found within E3 proteins, in combination with
either zinc-finger RING (IPR001841) or HECT (IPR000569) do-
mains. The Basic helix-loop-helix dimerization domain
(IPR001092) is also found in a human ubiquitin thiolesterase
family 2 (IPR001394) containing DUB. The tyrosine protein
kinase domain (IPR001245), on the other hand, is found in
proteins from the N/A class that contain the UBA domain
(IPR000449); there are eight human proteins carrying this
combination, one in mouse, two in D. melanogaster, and one
in C. elegans.
Only four non-UA domains were found to be specific to
mouse and human UA proteins: HMG-I and HMG-Y DNA-
binding domain (IPR000637), sterile  motif SAM
(IPR001660), butyrophylin-like (IPR003879), and fibronectin
type III repeat (IPR003962). All four of these domains appear
in combination within the zinc-finger RING domain
(IPR001841). Both the butyrophylin-like (IPR003879) domain
and the fibronectin type III repeat (IPR003962) are absent
within zinc-finger RING (IPR001841) proteins from the En-
sembl Fugu Database.
DISCUSSION
This analysis suggests that, as stated previously (Von Armin
2001; Jones et al. 2002), there may be a direct relationship
between the number of E2 proteins and developmental com-
plexity, but also that a similar case can be made for the num-
bers of proteins occupying the other enzyme classes. It is clear
that most evolutionary innovation in UA proteins has oc-
curred within E3 proteins, particularly those containing zinc-
finger RING (IPR001841), F-box (IPR001810), or HECT
(IPR000569) domains. However, lineage-specific explosions
in E3 numbers, as with the F-box (IPR001810)—containing
proteins in C. elegans, may obscure the real relationship be-
tween the numbers of proteins in an enzyme class and an-
other parameter such as developmental complexity. In addi-
tion, because E3 proteins are concerned with substrate recog-
nition, one would expect to see their numbers directly related
to total proteome size, which should confound any relation-
ship with developmental complexity. It seems premature to
draw any firm conclusions about ubiquitination and develop-
ment from such comparisons. It may be more informative to
examine differences between organisms at the level of the
component domains for each class, both in terms of the num-
bers and architectures of the proteins that possess these do-
mains.
The differences in numbers of ubiquitin thiolesterase
family 2 DUBs and proteins containing the N/A class do-
mains, such as UIM (IPR003903) and UBA (IPR000449), are
arguably the most intriguing identified here. Early vertebrate
evolution seems to have involved a substantial increase in
ubiquitin thiolesterase family 2 domain (IPR001394) DUBs,
because there are 104 in the Ensembl Fugu database (an un-
known number of these may be fragmentary predictions and/
or encoded by pseudogenes). Most DUBs seem to have roles in
reversing, proof-reading, and introducing variations in ubiq-
uitination (Ben-Neriah 2002). The data here suggest that as
well as ubiquitin conjugation and ligation, the de-
ubiquitination process has also been exploited to achieve ever
more intricate regulation of proteolysis in vertebrates. The
roles of several domains examined here have yet to be fully
described, although recently some progress has been made
with the UIM (IPR003903). The UIM has been shown to be
necessary for the mono-ubiquitination of mouse protein sub-
strates, leading to their inclusion in endocytic vesicles (Polo et
al. 2002). The substrates then become cargo in intracellular
membrane trafficking pathways and an extensive UIM-
ubiquitin-based intracellular network has been postulated on
the basis of these results (Polo et al. 2002). In this context, it
is interesting that vertebrate evolution has involved an in-
crease in UIM-containing proteins relative to other sequenced
organisms, presumably increasing the size of any associated
intracellular network. The Ensembl Fugu database contains
only up to 13 UIM-containing proteins, suggesting that the
elaboration of this network has continued since the diver-
gence of fish and mammals. The UBA domain (IPR000449) is
likely to be a general multi-ubiquitin binding domain
(Wilkinson et al. 2001) but also seems to mediate dimeriza-
tion (Bertolaet et al. 2001). The Ensembl Fugu database con-
tains up to 79 UBA containing proteins, and so, this domain
also seems to have expanded in numbers since the emergence
of vertebrates, although perhaps not since the divergence of
fish and mammals.
If one wishes to draw conclusions about the different
cellular and developmental roles that ubiquitination has
evolved to regulate, then it is instructive to study the broader
architectural differences between UA classes across different
organisms. Since the emergence of multicellular eukaryotes,
three domains seem to have been added to the repertoire of
E3 (and human DUB) proteins: the zinc-finger ZZ type do-
main (which has an unknown function), the basic helix-loop-
helix dimerization domain (which is present in transcription
factors, influencing a variety of developmental pathways),
and the ankyrin repeat (which functions as a protein–protein
interaction domain). During the same time, the tyrosine pro-
tein kinase domain (which is involved in the response of eu-
karyotic cells to external stimuli) has been partnered with the
UBA domain. Since the evolution of vertebrates, the HMG-I
and HMG-Y DNA-binding domain (which may function in
mRNA processing) and sterile motif (which is believed to be
involved in the regulation of numerous developmental pro-
cesses) have been added to zinc-finger RING domain E3 pro-
teins. At a later stage in vertebrate evolution, after the diver-
gence of fish and mammals, this same family of E3 proteins
has acquired the butyrophylin-like domain (which has no
known function but is found within transcription factors, ri-
bonucleoproteins, and proto-oncoproteins) and the fibronec-
tin type III repeat (which is found in a variety of cell surface
binding proteins).
Future work uncovering the cellular roles of ubiquitina-
tion that are universal across eukaryotes may benefit from
investigation of the non-UA domains found to be present
within E3 proteins from every species examined. The func-
tions of these non-UA domains cover signaling, endocytosis,
splicing, and transcriptional regulation. Some fundamental
observations can be made about the progressive integration of
ubiquitination into the life of the eukaryotic cell throughout
evolution. Several cellular processes have been linked to ubiq-
uitination since the emergence of eukaryotes: the cell cycle,
RNA processing and the regulation of transcription, intracel-
lular transport, and signaling pathways. Throughout eukary-
otic evolution, an ever more diverse variety of links have ap-
peared between ubiquitination and such cellular processes.
These links have predominantly been achieved through in-
novations in the architecture of three families of E3s (possess-




uitin thiolesterase family 2 DUBs. However, other, presently
less well understood families of UA proteins (possessing UBA,
UIM, and other domains) have also contributed to the diver-
sity of these links. It would appear that the emergence of
multicellular organisms and then of vertebrates have been
associated with much of this innovation, which has led to
novel connections with RNA processing and signaling as well
as involvement in the regulation of developmental pathways.
This steady increase in the cellular connectivity of ubiquiti-
nation is likely to have increased the opportunity for fine
regulation of the associated cellular processes.
METHODS
A nonredundant, although incomplete, Mus musculus pro-
teome (based upon proteins from SWISS-PROT and TrEMBL
and additional peptides predicted by Ensembl) was obtained
from the EBI Proteome Analysis Database (http://
www.ebi.ac.uk/proteome/; Apweiler et al. 2001). The EBI data
set retrieved (30,900 proteins as of August 28, 2002) was al-
tered to remove all proteins predicted from FANTOM2 clone
sequences, as indicated in either the name or description
fields of the protein entry. This altered EBI data set appears as
SPTRENS in Table 1. This alteration allowed the real contri-
bution of novel proteins from RTPS6 to be calculated. UA
proteins from both the SPTRENS set and the RTPS6 were de-
fined by the presence of the InterPro domains listed below.
This SPTRENS set was then combined with proteins from the
RTPS6 to produce the total UA M. musculus proteins referred
to in Table 2. Matches between RTPS6 proteins and those
from SPTRENS of 98% identity over 20 residues were as-
sumed to indicate that both sequences originated from the
same gene. This may underestimate the actual number of
genes if the data set contains many recent paralogs. An addi-
tionalM. musculus proteome, composed only of proteins from
SWISS-PROT and TrEMBL (SPTR in Table 1), was also retrieved
from the EBI Proteome Analysis Database, to estimate the rela-
tive success of novel gene identification strategies based upon
genomic or transcribed sequence. At the same time (August,
28, 2002), nonredundant protein sets for Homo sapiens
(33,451 protein entries derived from SWISS-PROT, TrEMBL
and Ensembl), C. elegans (20,046 proteins), D. melanogaster
(15,253 proteins), S. pombe (5051), and S. cerevisiae (6206 pro-
teins) proteomes were also retrieved from the same source.
The methods used to reduce redundancy vary between the
proteome sets referred to here. The FANTOM2 RTPS6 set was
constructed by using mapping to the genome to reduce re-
dundancy, and when a finished genome sequence is available,
the EBI follows an analogous strategy. However, when a fin-
ished genome sequence is not available (for mouse and hu-
man sets), mapping to the genome sequences cannot always
provide a definitive answer. Consequently, the EBI uses an-
other method of reducing redundancy: liberal clustering of all
proteins sharing sequence similarity, with each cluster treated
as a single database entry. These strategies are discussed in
detail at the EBI Proteome Analysis Database site (http://
www.ebi.ac.uk/proteome/). All data sets used in this study are
avai lable f rom http: / /www.hgu.mrc .ac .uk/Users/
Colin.Semple/lab_data.html.
Given the incomplete nature of the sequence data for
some of these organisms and the degree of error inherent in
gene prediction, each of these data sets would be expected to
contain a number of incomplete fragmentary protein se-
quences. It is not a trivial task to derive accurate estimates of
these numbers. However, to assess the scale of this problem,
the proportions of proteins from each proteome indicated to
be fragmentary (within the database name or description
fields) were recorded as follows: H. sapiens, 0.12; M. musculus,
0.09; D. melanogster, 0.01; C. elegans, 0.001; S. pombe, 0.05;
and S. cerevisiae, 0.01. This indicates that fragmentary proteins
are most prevalent in H. sapiens andM. musculus data, and the
equivalent proportions for UA proteins in these species are
0.13 and 0.05, respectively. One may conclude that some cau-
tion should be exercised in interpreting comparisons involv-
ing these two proteomes. Some comparisons involved pre-
dicted proteins from the recently sequenced draft genome
sequence of the puffer fish Fugu rubripes (Ensembl Fugu Data-
base Release 8.1.1; http://www.ensembl.org/Fugu_rubripes/).
Given the lack of transcribed sequence data for F. rubripes and
the unfinished state of its genome sequence, these predicted
proteins should also be regarded as potentially incomplete,
fragmentary and/or artifactual.
The UA InterPro domains examined were as follows:
1. the three E1 domains: UBA/THIF-type NAD/FAD binding
fold domain (IPR000594), E1 replicated domain
(IPR000127), and E1 domain (IPR000011);
2. the single E2 domain: E2 domain (IPR000608);
3. the seven E3 domains: SKP1 component domain
(IPR001232), F-box domain (IPR001810), Cullin domain
(IPR001373), HECT domain (IPR000569), zinc-finger (pu-
tative), N-recognin domain (IPR003126), zinc-finger RING
domain (IPR001841), and zinc-finger–modified RING do-
main (also called Ubox; IPR003613);
4. the three DUB domains: ubiquitin C-terminal hydrolase
family 1 domain (IPR001578), ubiquitin thiolesterase fam-
ily 2 domain (IPR001394), zinc-finger in ubiquitin thioles-
terase domain (IPR001607);
5. six other domains (assigned to the N/A class because other
classes are not applicable at present), for which we lack a
precise knowledge of their roles in ubiquitination, were
also included: ubiquitin domain (IPR000626; a number of
proteins contain ubiquitin-like domains with unknown
functions that are similar to the ubiquitin molecule itself),
UBA domain (IPR000449; recently shown to bind multi-
ubiquitin chains), UBX domain (IPR001012; function un-
known but may be involved in apoptosis), CUE domain
(IPR003892; may be involved in binding E2s), ubiquitin
interacting motif (IPR003903; involved with mono-
ubiquitination of substrates leading to endocytosis), and
ubiquitin fusion degradation protein UFD1 (IPR004854;
involved in the recognition of ubiquitin–protein conju-
gates leading to degradation).
Unless otherwise stated, the functional description of
these domains is derived from the appropriate InterPro en-
tries. Contemporary references for each domain can also be
viewed at the InterPro site (http://www.ebi.ac.uk/interpro/
index.html). It is important to note that InterPro assignments
are not infallible, and occasionally, a single domain may be
annotated as belonging to two different categories; an ex-
ample encountered in these data was completely overlapping
predictions of RING finger (IPR001841) and PHD finger
(IPR001965) domains. Annotation for all proteins of interest
can be viewed in its entirety using the graphical annotation
viewer provided by FANTOMDB (http://fantom2.gsc.riken.
go.jp/db/).
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